DirectSync Surgical
Fred Meyer, PhD, CFA, serves as the Entrepreneur in Residence at the Institute for Advancing Medical Innovation at the University of Kansas Medical Center, focusing on translating laboratory discoveries into medical innovations, particularly in cancer and rare diseases. In addition to this role, Fred Meyer acts as a Board Observer for DirectSync Surgical, a medical device company, and a Business Development Advisor for DCLK1 LLC, which seeks novel treatments for cholangiocarcinoma. With extensive experience as a life science strategy advisor, Fred Meyer has held significant positions at various organizations, including member of the board at eXIthera Pharmaceuticals, and leadership roles at Xcovery and Tyrogenex, which both develop critical therapies in oncology. Fred Meyer co-founded Benu BioVentures and has a background in corporate development at LipimetiX Development. Educationally, Fred Meyer holds a PhD in Molecular Genetics from The Ohio State University and a BS with Honors in Genetics & Development from the University of Illinois Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
DirectSync Surgical
(Formerly Evoke Medical) Our mission is to research & develop osteoinductive piezoelectric biomaterials in order to improve patient outcomes, reduce healthcare costs, and streamline the clinical episode of care with the singular goal of improving humanity’s quality of life. We leverage the human body’s mechanical biofeedback system to design disruptive “smart implants” that heal bone using natural bone forming pathways.